Displaying 96 - 100 of 198
Fri 04 December 2015
We're delighted to hear that we have once again been awarded an AMRC (Association of Medical Research Charities) Best Practice certificate in the most recent Peer Review Audit 2015.Read More about 'Certificate of Best Practice award to acknowledge the quality of our research programme'
Wed 18 November 2015
Scientists at Ulster University are currently working on an exciting new strategy for the fight against pancreatic cancer. The team has made a major breakthrough in the early stages of developing a potential new, minimally invasive treatment, activated by harmless sound waves, also known as ultrasound.Read More about 'New treatment for pancreatic cancer using oxygen bubbles under development'
Tue 17 November 2015
The Scottish Government’s Chief Scientist Office (CSO), Pancreatic Cancer Scotland and Pancreatic Cancer UK are today announcing that for the first time, they will co-fund almost £500,000 of pancreatic cancer research in Scotland.Read More about 'Scottish scientists to carry out almost £500,000 of ground breaking research'
Tue 10 November 2015
New data released today (Tuesday, 10th November) shows that nearly half (45 per cent) of pancreatic cancer cases in 2013 were diagnosed as a result of an emergency presentation at hospital. This is more than double the average rate of 20 per cent for all other cancer types.Read More about 'High numbers of pancreatic cancer patients still diagnosed via emergency route'
Wed 04 November 2015
We are outraged that as of today, (Wednesday 4th November), the life-extending drug Abraxane is no longer available to newly eligible patients with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF).Read More about 'Life extending drug no longer available to new patients with advanced pancreatic cancer in England'